Early Diagnosis in Dedicator of Cytokinesis 8 (DOCK8) Deficiency

Journal of Pediatrics

Volumn 179, Issue , 2016, Pages 33-35

  Chang, Deidre R ^a   Toh, Jennifer ^b   de Vos, Gabriele ^c   Gavrilova, Tatyana ^b  

^a ST BARNABAS HOSPITAL   (United States)

^b CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

^c JACOBI MEDICAL CENTER   (United States)

Author keywords

autosomal recessive HIES; combined immunodeficiency; DOCK8 deficiency; HIES; Hyper immunoglobulin E syndrome

Indexed keywords

ACICLOVIR; BUDESONIDE; BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN E; DOCK8 PROTEIN, HUMAN; GUANINE NUCLEOTIDE EXCHANGE FACTOR;

ARTICLE; ATOPIC DERMATITIS; CASE REPORT; CHILD; CLINICAL FEATURE; DEDICATOR OF CYTOKINESIS 8 DEFICIENCY; DERMATITIS; EARLY DIAGNOSIS; EOSINOPHIL COUNT; ERYTHROCYTE SEDIMENTATION RATE; FOOD ALLERGY; GENETIC SCREENING; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPETIC STOMATITIS; HIRSUTISM; HUMAN; HYPER IGE SYNDROME; KERATITIS; MALE; OUTCOME ASSESSMENT; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; COMPLICATION; DEFICIENCY; IMMUNE DEFICIENCY; INFANT;

EARLY DIAGNOSIS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; MALE;

EID: 84995803134     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2016.08.081     Document Type: Article

References (18)

1. 1 Holland, S.M., DeLeo, F.R., Elloumi, H.Z., Hsu, A.P., Uzel, G., Brodsky, N., et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 357 (2007), 1608–1619.
2. 2 Boos, A.C., Hagl, B., Schlesinger, A., Halm, B.E., Ballenberger, N., Pinarci, M., et al. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern. Allergy 69 (2014), 943–953.
3. 3 Zhang, Q., Davis, J.C., Lamborn, I.T., Freeman, A.F., Jing, H., Favreau, A.J., et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med 361 (2009), 2046–2055.
4. 4 Hill, H.R., Quie, P.G., Raised serum-IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections. Lancet 1 (1974), 183–187.
5. 5 Koskenvuo, M., Kainulainen, L., Vanto, T., Lukkarinen, H., Lahteenmaki, P., Ruuskanen, O., Severe atopy and allergy—rare hyper-IgE syndrome caused by the DOCK8 mutation as underlying condition. Duodecim 131 (2015), 541–544.
6. 6 Chu, E.Y., Freeman, A.F., Jing, H., Cowen, E.W., Davis, J., Su, H.C., et al. Cutaneous manifestations of DOCK8 deficiency syndrome. Arch Dermatol 148 (2012), 79–84.
7. 7 Zhang, Y., Yu, X., Ichikawa, M., Lyons, J.J., Datta, S., Lamborn, I.T., et al. Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment. J Allergy Clin Immunol 133 (2014), 1400–1409 9 e1-5.
8. 8 Singh, A.K., Eken, A., Fry, M., Bettelli, E., Oukka, M., DOCK8 regulates protective immunity by controlling the function and survival of RORgammat+ ILCs. Nat Commun, 5, 2014, 4603.
9. 9 Aydin, S.E., Kilic, S.S., Aytekin, C., Kumar, A., Porras, O., Kainulainen, L., et al. DOCK8 deficiency: clinical and immunological phenotype and treatment options—a review of 136 patients. J Clin Immunol 35 (2015), 189–198.
10. 10 Zhang, Q., Dove, C.G., Hor, J.L., Murdock, H.M., Strauss-Albee, D.M., Garcia, J.A., et al. DOCK8 regulates lymphocyte shape integrity for skin antiviral immunity. J Exp Med 211 (2014), 2549–2566.
11. 11 Janssen, E., Morbach, H., Ullas, S., Bannock, J.M., Massad, C., Menard, L., et al. Dedicator of cytokinesis 8-deficient patients have a breakdown in peripheral B-cell tolerance and defective regulatory T cells. J Allergy Clin Immunol 134 (2014), 1365–1374.
12. 12 Krishnaswamy, J.K., Singh, A., Gowthaman, U., Wu, R., Gorrepati, P., Sales Nascimento, M., et al. Coincidental loss of DOCK8 function in NLRP10-deficient and C3H/HeJ mice results in defective dendritic cell migration. Proc Natl Acad Sci USA 112 (2015), 3056–3061.
13. 13 Harada, Y., Tanaka, Y., Terasawa, M., Pieczyk, M., Habiro, K., Katakai, T., et al. DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses. Blood 119 (2012), 4451–4461.
14. 14 Engelhardt, K.R., Gertz, M.E., Keles, S., Schaffer, A.A., Sigmund, E.C., Glocker, C., et al. The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol 136 (2015), 402–412.
15. 15 Janssen, E., Tsitsikov, E., Al-Herz, W., Lefranc, G., Megarbane, A., Dasouki, M., et al. Flow cytometry biomarkers distinguish DOCK8 deficiency from severe atopic dermatitis. Clin Immunol 150 (2014), 220–224.
16. 16 Boztug, H., Karitnig-Weiss, C., Ausserer, B., Renner, E.D., Albert, M.H., Sawalle-Belohradsky, J., et al. Clinical and immunological correction of DOCK8 deficiency by allogeneic hematopoietic stem cell transplantation following a reduced toxicity conditioning regimen. Pediatr Hematol Oncol 29 (2012), 585–594.
17. 17 Keles, S., Jabara, H.H., Reisli, I., McDonald, D.R., Barlan, I., Hanna-Wakim, R., et al. Plasmacytoid dendritic cell depletion in DOCK8 deficiency: rescue of severe herpetic infections with IFN-alpha 2b therapy. J Allergy Clin Immunol 133 (2014), 1753–1755 e3.
18. 18 Cuellar-Rodriguez, J., Freeman, A.F., Grossman, J., Su, H., Parta, M., Murdock, H., et al. Matched related and unrelated donor hematopoietic stem cell transplantation for DOCK8 deficiency. Biol Blood Marrow Transplant 21 (2015), 1037–1045.